Aurinia Pharmaceuticals (AUPH) Technical (Analysis) Reports Aurinia Pharmaceuticals ["Technical Analysis"] Reports -NASDAQ Stock Exchange MunafaSutra.com
Complete & easy to understand technical analysis of Aurinia Pharmaceuticals (AUPH)
Technical Analysis Report for NASDAQ stock AUPH Aurinia Pharmaceuticals. Dated: 07 Jan 2025 Updated Daily. Stock trades under Health Care Deals in Major Pharmaceuticals in NASDAQ stock exchange
If you are looking for Tomorrow's Movement Predictions for NASDAQ stock AUPH Aurinia Pharmaceuticals then click here. or read Experts views on Aurinia Pharmaceuticals or Forecast & share price targets of Aurinia Pharmaceuticals
Aurinia Pharmaceuticals Opened at 8.40 and Closed at: 8.42, which is 0.48% of previous session's close. It moved within a range of 8.34 and 8.57
The session was a Bullish session with an average volume of 1407500, which is -18.56% of previous session's volumes.
- Even though the stock has shown an up move, but the short term trend of the stock remains negative and in a downtrend.
- The stock has shown an up move, and its mid term trend is also positive and in an uptrend.
- The stock has shown an up move, and its long term trend is also positive and in an uptrend.
A Dead cross was found 6 days back on short term averages
Support for tomorrow is 8.38 and resistance for tomorrow is 8.61
These support and resistance points are valid for the first 5-15 minutes charts
Above are simple pivot point calculations. For a list of much stronger support and resistance levels click here. These are way more stronger support and resistance levels, and mark trend reversals and are Support & Resistance levels recommended by experts.
Support for tomorrow's hourly charts is 8.32, 8.21 resistance for tomorrow's hourly charts is 8.55, 8.67
10 Day SMA for Aurinia Pharmaceuticals (AUPH) is 8.86 and stock is trading below these levels. This is not a good sign for its short term trend
20 Day SMA for Aurinia Pharmaceuticals (AUPH) is 9.19 and the stock is trading below these levels. This is not a good sign for its mid term trend
50 Day SMA for Aurinia Pharmaceuticals (AUPH) is 8.37 and the stock is trading above these levels. This is a good sign for its mid to long term trend
100 Day SMA is 7.57 and the stock is trading above these levels. This is a good sign for its long term trend
200 Day SMA Aurinia Pharmaceuticals is 6.46 and stock is trading above these levels. This is a good sign for its long term trend
20 DMA of Aurinia Pharmaceuticals is at 9.19 and 200 DMA is at 6.46, while 50 DMA and 100 DMA are at 8.37 and 7.57 respectively
Aurinia Pharmaceuticals (AUPH) moving average of 20 SMA is at 9.19 and 20 EMA is at 8.86
| Date | Closing Price | 20 SMA | 20 EMA |
| 07 Tue Jan | 8.42 | 9.19 | 8.86 |
| 06 Mon Jan | 8.38 | 9.2 | 8.91 |
| 03 Fri Jan | 8.54 | 9.22 | 8.97 |
| 02 Thu Jan | 8.77 | 9.23 | 9.01 |
| 31 Tue Dec | 8.96 | 9.23 | 9.03 |
| 30 Mon Dec | 9.17 | 9.22 | 9.04 |
Aurinia Pharmaceuticals (AUPH) moving average of 50 SMA is at 8.37 and 50 EMA is at 8.43
| Date | Closing Price | 50 SMA | 50 EMA |
| 07 Tue Jan | 8.42 | 8.37 | 8.43 |
| 06 Mon Jan | 8.38 | 8.34 | 8.43 |
| 03 Fri Jan | 8.54 | 8.32 | 8.43 |
| 02 Thu Jan | 8.77 | 8.29 | 8.43 |
| 31 Tue Dec | 8.96 | 8.26 | 8.42 |
| 30 Mon Dec | 9.17 | 8.22 | 8.4 |
Aurinia Pharmaceuticals (AUPH) moving average of 100 SMA is at 7.57 and 100 EMA is at 7.78
| Date | Closing Price | 100 SMA | 100 EMA |
| 07 Tue Jan | 8.42 | 7.57 | 7.78 |
| 06 Mon Jan | 8.38 | 7.54 | 7.77 |
| 03 Fri Jan | 8.54 | 7.51 | 7.76 |
| 02 Thu Jan | 8.77 | 7.48 | 7.74 |
| 31 Tue Dec | 8.96 | 7.45 | 7.72 |
| 30 Mon Dec | 9.17 | 7.41 | 7.69 |
Aurinia Pharmaceuticals (AUPH) moving average of 200 SMA is at 6.46 and 200 EMA is at 7.39
| Date | Closing Price | 200 SMA | 200 EMA |
| 07 Tue Jan | 8.42 | 6.46 | 7.39 |
| 06 Mon Jan | 8.38 | 6.44 | 7.38 |
| 03 Fri Jan | 8.54 | 6.42 | 7.37 |
| 02 Thu Jan | 8.77 | 6.41 | 7.36 |
| 31 Tue Dec | 8.96 | 6.39 | 7.35 |
| 30 Mon Dec | 9.17 | 6.37 | 7.33 |
Veracyte Inc has performed better than Aurinia Pharmaceuticals in short term. You could have earned much better returns by investing in Veracyte Inc, about 7.16% more returns!
Sol Gel has performed better than Aurinia Pharmaceuticals in short term. You could have earned much better returns by investing in Sol Gel, about 177.11% more returns!
Repros Therapeutics has performed better than Aurinia Pharmaceuticals in short term. You could have earned much better returns by investing in Repros Therapeutics, about 8% more returns!
Neurometrix Inc has performed better than Aurinia Pharmaceuticals in short term. You could have earned much better returns by investing in Neurometrix Inc, about 6.42% more returns!
Neurotrope Inc has performed better than Aurinia Pharmaceuticals in short term. You could have earned much better returns by investing in Neurotrope Inc, about 81.32% more returns!
Halozyme Therapeutics has performed better than Aurinia Pharmaceuticals in short term. You could have earned much better returns by investing in Halozyme Therapeutics, about 12.2% more returns!
Galmed Pharmaceuticals has performed better than Aurinia Pharmaceuticals in short term. You could have earned much better returns by investing in Galmed Pharmaceuticals, about 10.98% more returns!
Dbv Technologies has performed better than Aurinia Pharmaceuticals in short term. You could have earned much better returns by investing in Dbv Technologies, about 7.31% more returns!
Aurinia Pharmaceuticals has performed better than Corbus Pharmaceuticals in short term. Holding Aurinia Pharmaceuticals could be a better choice for now!
Cidara Therapeutics has performed better than Aurinia Pharmaceuticals in short term. You could have earned much better returns by investing in Cidara Therapeutics, about 27.83% more returns!
Aurinia Pharmaceuticals has performed better than Audentes Therapeutics in short term. Holding Aurinia Pharmaceuticals could be a better choice for now!
Aurinia Pharmaceuticals has performed better than Axsome Therapeutics in short term. Holding Aurinia Pharmaceuticals could be a better choice for now!
Assertio Therapeutics has performed better than Aurinia Pharmaceuticals in short term. You could have earned much better returns by investing in Assertio Therapeutics, about 0.35% more returns!
Alnylam Pharmaceuticals has performed better than Aurinia Pharmaceuticals in short term. You could have earned much better returns by investing in Alnylam Pharmaceuticals, about 0.4% more returns!
Aurinia Pharmaceuticals has performed better than Alkermes Plc in short term. Holding Aurinia Pharmaceuticals could be a better choice for now!
Arbutus Biopharma has performed better than Aurinia Pharmaceuticals in short term. You could have earned much better returns by investing in Arbutus Biopharma, about 0.8% more returns!
Aurinia Pharmaceuticals Technical analysis of indicators
Price action analysis of Aurinia Pharmaceuticals (AUPH) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
ADX buy sell signal for Aurinia Pharmaceuticals stock for short term is SELL. Signal strength is Strong and stock is gaining momentum.
MACD generated a SELL signal for Aurinia Pharmaceuticals in short term but the sell signal is initial and weak.
Aurinia Pharmaceuticals Stock is trading near its recent LOWS in short term which reflects strong selling momentum. Bears are weakening, and bulls are picking up momentum!
Ichimoku cloud is of green color and prices are in or below the green cloud Prices appear to be moving up
CCI has generated a SELL signal for Aurinia Pharmaceuticals in short term and SELL signal is strong!
RSI is generating a BUY signal in short term but buying is losing momentum.
MRSI is in negative zone. This is the SELL zone
Although the stock is in the SELL zone, but selling might be slowing down
Stock of Aurinia Pharmaceuticals is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 8.78 and Aurinia Pharmaceuticals AUPH stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Aurinia Pharmaceuticals AUPH stock. Volume based technical analysis of Aurinia Pharmaceuticals AUPH stock is negative.
Aurinia Pharmaceuticals Stock has given negative returns over a short term period. Returns for a longer term period have been positive
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Tomorrow's Predictions
You should also read Tomorrow's Movement Predictions for NASDAQ stock AUPH Aurinia Pharmaceuticals These predictions are based on various factors, are easy to understand, and upto 75% accurate!
And AUPH Experts View which covers a lot of information including buying and selling signals
AUPH future forecast & share price targets
You can also take a look at the Charts and indicator analysis here Announcements & NEWS by Aurinia Pharmaceuticals or View Candle Stick Charts here
Quick Charts: Renko Point & Figure Just IntraDay All Indicators Weekly Monthly All in One Eagle View MACD & ADX
Videos related to: Aurinia Pharmaceuticals (AUPH) Technical (Analysis) Reports Aurinia Pharmaceuticals ["Technical Analysis"] Reports -NASDAQ Stock Exchange MunafaSutra.com
Hindi Video Correct Way Of Technical Analysis How To Find Entry Exit Points On Charts
Hindi Video Most Important Stock Market Video. No Success Without This Formula
- NASDAQ Screeners
- NASDAQ Daily Screener
- NASDAQ Weekly Screener
- NASDAQ Monthly Screener
- Support & Resistance
- NASDAQ Shares Near Support
- NASDAQ Shares Near Resistance